cytogenic


Also found in: Dictionary, Thesaurus.
Related to cytogenic: cytogenic reproduction

cytogenic

 [si″to-jen´ik]
1. pertaining to cytogenesis.
2. forming or producing cells.

cy·to·gen·ic

(sī'tō-jen'ik),
Relating to cytogenesis.

cy·to·gen·ic

(sī'tō-jen'ik)
Relating to cytogenesis.
References in periodicals archive ?
(ii) Unexpectedly, increased cytogenic abnormalities in number and severity were recorded in cells, cultured with antioxidant supplementation.
The effect of cement dust exposure on hematological and cytogenic studies of cement workers.
No specific translocations or genetic abnormalities in humans have been identified to cause OS; (14,50,54) However, approximately 70% of OS tumor cells display the contribution of some genetic variation, which leads to cytogenic abnormalities (54,55).
Cytogenic effects of cyanazine and metolachlor on human lymphocytes exposed in vitro.
While limited in number, studies performed to assess the effect of methylation on chromosome segregation have consistently shown an increase in the frequency of cytogenic abnormalities associated with perturbations in the methylation status of chromosomes [67].
The MGMT enzyme removes mutagenic and cytogenic adducts from O6-guanine in DNA, via a one-step methyl transfer reaction (Lindahl et al., 1988).
(5) Histopathological analysis (and sometimes even special immunohistochemical staining and cytogenic analysis) can be used to make a definitive diagnosis.
Cytogenic analyses were performed, investigating specifically the role of a primitive tissue known as a[euro]oeundifferentiated gonadal tissue.
Other than pleuropulmonary blastoma family tumor and dysplasia syndrome, a rare syndrome related to germline mutation of DICER1 gene, most intraocular medulloepitheliomas occur sporadically and are not associated with congenital malformation or cytogenic abnormality.
21 November 2011 - Celgene International Sarl, part of US Celgene Corp (NASDAQ:CELG), said today that the Swiss agency for Therapeutic Products (Swissmedic) had cleared REVLIMID (lenalidomide) to treat patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) related to a deletion 5q cytogenic abnormality with or without additional cytogenic abnormalities.
Cytogenic study showed 46XY/46XX mosaic chromosomal pattern.